nach oben

Clinical Rheumatology

Erschienen in:

25.02.2020 | Original Article

The association between synovial fluid serine proteinase activity and response to intra-articular corticosteroid injection in psoriatic arthritis

verfasst von: Fatima Abji, Justine Yang Ye, Richard J Cook, Katerina Oikonomopoulou, Vinod Chandran

Erschienen in: Clinical Rheumatology | Ausgabe 8/2020

Einloggen, um Zugang zu erhalten

Abstract

Introduction/objectives

Intra-articular corticosteroid (IAS) injections are often used for the immediate relief of pain and inflammation in the joint of psoriatic arthritis (PsA) patients. However, studies identifying factors that predict response to the IAS injections are lacking. We aimed to assess the usefulness of serine proteinase activity measurements in PsA synovial fluid (SF) samples obtained at the time of injection in predicting clinical response.

Methods

The PsA patients with available SF samples from the knee joint were identified from the University of Toronto PsA cohort. Clinical response was defined as an absence of tenderness or swelling in the injected joint at the first post-injection visit, at either 3 or 6 months. SF proteinase activity was determined by measuring cleavage of fluorogenic tri-peptide substrates for trypsin-like (VPR-AMC and VLK-AMC) and chymotrypsin-like (AAPF-AMC) serine proteinases. Generalized estimating equation (GEE) models were used to investigate factors associated with response.

Results

A total of 32 patients with 60 injected joints and data available for follow-up at 3 or 6 months were included in the analysis, with 25 (41.7%) injected joints resulting in clinical response. Age, sex, active joint count, systemic medications and SF serine proteinase activity at the time of injection were included as covariates. Only treatment with biologics was significantly associated with response at 3 or 6 months in the multivariate reduced model (OR 3.02, p = 0.027).

Conclusions

We could not demonstrate an association between SF serine proteinase activity and response to IAS injection. Biologic agents significantly improve the likelihood of achieving clinical response.

Jennings H, Hennessy K, Hendry GJ (2014) The clinical effectiveness of intra-articular corticosteroids for arthritis of the lower limb in juvenile idiopathic arthritis: a systematic review. Pediatr Rheumatol Online J 12:23. https://doi.org/10.1186/1546-0096-12-23CrossRefPubMedPubMedCentral

Wallen M, Gillies D (2006) Intra-articular steroids and splints/rest for children with juvenile idiopathic arthritis and adults with rheumatoid arthritis. Cochrane Database Syst Rev 1:CD002824. https://doi.org/10.1002/14651858.CD002824.pub2CrossRef

Juni P, Hari R, Rutjes AW, Fischer R, Silletta MG, Reichenbach S, da Costa BR (2015) Intra-articular corticosteroid for knee osteoarthritis. Cochrane Database Syst Rev 10:CD005328. https://doi.org/10.1002/14651858.CD005328.pub3CrossRef

Coates LC, Kavanaugh A, Mease PJ, Soriano ER, Laura Acosta-Felquer M, Armstrong AW, Bautista-Molano W, Boehncke WH, Campbell W, Cauli A, Espinoza LR, FitzGerald O, Gladman DD, Gottlieb A, Helliwell PS, Husni ME, Love TJ, Lubrano E, McHugh N, Nash P, Ogdie A, Orbai AM, Parkinson A, O’Sullivan D, Rosen CF, Schwartzman S, Siegel EL, Toloza S, Tuong W, Ritchlin CT (2016) Group for research and assessment of psoriasis and psoriatic arthritis 2015 treatment recommendations for psoriatic arthritis. Arthritis & rheumatology (Hoboken, NJ) 68(5):1060–1071. https://doi.org/10.1002/art.39573CrossRef

Carubbi F, Zugaro L, Cipriani P, Conchiglia A, Gregori L, Danniballe C, Letizia Pistoia M, Liakouli V, Ruscitti P, Ciccia F, Triolo G, Masciocchi C, Giacomelli R (2016) Safety and efficacy of intra-articular anti-tumor necrosis factor alpha agents compared to corticosteroids in a treat-to-target strategy in patients with inflammatory arthritis and monoarthritis flare. Int J Immunopathol Pharmacol 29(2):252–266. https://doi.org/10.1177/0394632015593220CrossRefPubMed

Eder L, Chandran V, Ueng J, Bhella S, Lee KA, Rahman P, Pope A, Cook RJ, Gladman DD (2010) Predictors of response to intra-articular steroid injection in psoriatic arthritis. Rheumatology (Oxford) 49(7):1367–1373. https://doi.org/10.1093/rheumatology/keq102CrossRef

Kirwan JR (1995) The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group. N Engl J Med 333(3):142–146. https://doi.org/10.1056/NEJM199507203330302CrossRefPubMed

Makrygiannakis D, af Klint E, Catrina SB, Botusan IR, Klareskog E, Klareskog L, Ulfgren AK, Catrina AI (2006) Intraarticular corticosteroids decrease synovial RANKL expression in inflammatory arthritis. Arthritis Rheum 54(5):1463–1472. https://doi.org/10.1002/art.21767CrossRefPubMed

Oikonomopoulou K, Diamandis EP, Hollenberg MD, Chandran V (2018) Proteinases and their receptors in inflammatory arthritis: an overview. Nat Rev Rheumatol 14(3):170–180. https://doi.org/10.1038/nrrheum.2018.17CrossRefPubMed

10.

Martel-Pelletier J, Welsch DJ, Pelletier JP (2001) Metalloproteases and inhibitors in arthritic diseases. Best Pract Res Clin Rheumatol 15(5):805–829. https://doi.org/10.1053/berh.2001.0195CrossRefPubMed

11.

Burrage PS, Mix KS, Brinckerhoff CE (2006) Matrix metalloproteinases: role in arthritis. Front Biosci 11:529–543CrossRef

12.

MullerLadner U, Gay RE, Gay S (1996) Cysteine proteinases in arthritis and inflammation. Perspect Drug Discov 6:87–98. https://doi.org/10.1007/Bf02174047CrossRef

13.

Delaisse JM, Andersen TL, Engsig MT, Henriksen K, Troen T, Blavier L (2003) Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities. Microsc Res Tech 61(6):504–513. https://doi.org/10.1002/jemt.10374CrossRefPubMed

14.

Cunnane G, FitzGerald O, Hummel KM, Youssef PP, Gay RE, Gay S, Bresnihan B (2001) Synovial tissue protease gene expression and joint erosions in early rheumatoid arthritis. Arthritis Rheum 44(8):1744–1753. https://doi.org/10.1002/1529-0131(200108)44:8<1744::aid-art309>3.0.co;2-kCrossRefPubMed

15.

Rengel Y, Ospelt C, Gay S (2007) Proteinases in the joint: clinical relevance of proteinases in joint destruction. Arthritis research & therapy 9(5):221. https://doi.org/10.1186/ar2304CrossRef

16.

Cretu D, Prassas I, Saraon P, Batruch I, Gandhi R, Diamandis EP, Chandran V (2014) Identification of psoriatic arthritis mediators in synovial fluid by quantitative mass spectrometry. Clin Proteomics 11(1):27. https://doi.org/10.1186/1559-0275-11-27CrossRefPubMedPubMedCentral

17.

Jadon DR, Sengupta R, Nightingale A, Lu H, Dunphy J, Green A, Elder JT, Nair RP, Korendowych E, Lindsay MA, McHugh NJ (2017) Serum bone-turnover biomarkers are associated with the occurrence of peripheral and axial arthritis in psoriatic disease: a prospective cross-sectional comparative study. Arthritis Res Ther 19(1):210. https://doi.org/10.1186/s13075-017-1417-7CrossRefPubMedPubMedCentral

18.

Sun S, Bay-Jensen AC, Karsdal MA, Siebuhr AS, Zheng Q, Maksymowych WP, Christiansen TG, Henriksen K (2014) The active form of MMP-3 is a marker of synovial inflammation and cartilage turnover in inflammatory joint diseases. BMC Musculoskelet Disord 15:93. https://doi.org/10.1186/1471-2474-15-93CrossRefPubMedPubMedCentral

19.

Weitoft T, Larsson A, Ronnblom L (2008) Serum levels of sex steroid hormones and matrix metalloproteinases after intra-articular glucocorticoid treatment in female patients with rheumatoid arthritis. Ann Rheum Dis 67(3):422–424. https://doi.org/10.1136/ard.2007.081315CrossRefPubMed

20.

Ricklin D, Hajishengallis G, Yang K, Lambris JD (2010) Complement: a key system for immune surveillance and homeostasis. Nat Immunol 11(9):785–797. https://doi.org/10.1038/ni.1923CrossRefPubMedPubMedCentral

21.

Trouw LA, Pickering MC, Blom AM (2017) The complement system as a potential therapeutic target in rheumatic disease. Nat Rev Rheumatol 13(9):538–547. https://doi.org/10.1038/nrrheum.2017.125CrossRefPubMed

22.

So AK, Varisco PA, Kemkes-Matthes B, Herkenne-Morard C, Chobaz-Peclat V, Gerster JC, Busso N (2003) Arthritis is linked to local and systemic activation of coagulation and fibrinolysis pathways. J Thromb Haemost 1(12):2510–2515CrossRef

23.

Busso N, Hamilton JA (2002) Extravascular coagulation and the plasminogen activator/plasmin system in rheumatoid arthritis. Arthritis Rheum 46(9):2268–2279. https://doi.org/10.1002/art.10498CrossRefPubMed

24.

Martel-Pelletier J, Faure MP, McCollum R, Mineau F, Cloutier JM, Pelletier JP (1991) Plasmin, plasminogen activators and inhibitor in human osteoarthritic cartilage. J Rheumatol 18(12):1863–1871PubMed

25.

Nakano S, Ikata T, Kinoshita I, Kanematsu J, Yasuoka S (1999) Characteristics of the protease activity in synovial fluid from patients with rheumatoid arthritis and osteoarthritis. Clin Exp Rheumatol 17(2):161–170PubMed

26.

Eissa A, Cretu D, Soosaipillai A, Thavaneswaran A, Pellett F, Diamandis A, Cevikbas F, Steinhoff M, Diamandis EP, Gladman D, Chandran V (2013) Serum kallikrein-8 correlates with skin activity, but not psoriatic arthritis, in patients with psoriatic disease. Clin Chem Lab Med 51(2):317–325. https://doi.org/10.1515/cclm-2012-0251CrossRefPubMed

27.

Moore AR, Appelboam A, Kawabata K, Da Silva JA, D’Cruz D, Gowland G, Willoughby DA (1999) Destruction of articular cartilage by alpha 2 macroglobulin elastase complexes: role in rheumatoid arthritis. Ann Rheum Dis 58(2):109–113CrossRef

28.

Miyata J, Tani K, Sato K, Otsuka S, Urata T, Lkhagvaa B, Furukawa C, Sano N, Sone S (2007) Cathepsin G: the significance in rheumatoid arthritis as a monocyte chemoattractant. Rheumatol Int 27(4):375–382. https://doi.org/10.1007/s00296-006-0210-8CrossRefPubMed

29.

Milner JM, Patel A, Davidson RK, Swingler TE, Desilets A, Young DA, Kelso EB, Donell ST, Cawston TE, Clark IM, Ferrell WR, Plevin R, Lockhart JC, Leduc R, Rowan AD (2010) Matriptase is a novel initiator of cartilage matrix degradation in osteoarthritis. Arthritis Rheum 62(7):1955–1966. https://doi.org/10.1002/art.27476CrossRefPubMed

30.

Wilkinson DJ, Habgood A, Lamb HK, Thompson P, Hawkins AR, Desilets A, Leduc R, Steinmetzer T, Hammami M, Lee MS, Craik CS, Watson S, Lin H, Milner JM, Rowan AD (2017) Matriptase induction of metalloproteinase-dependent aggrecanolysis in vitro and in vivo: promotion of osteoarthritic cartilage damage by multiple mechanisms. Arthritis & rheumatology (Hoboken, NJ) 69(8):1601–1611. https://doi.org/10.1002/art.40133CrossRef

31.

Nigrovic PA, Lee DM (2007) Synovial mast cells: role in acute and chronic arthritis. Immunol Rev 217:19–37. https://doi.org/10.1111/j.1600-065X.2007.00506.xCrossRefPubMed

32.

Nakano S, Mishiro T, Takahara S, Yokoi H, Hamada D, Yukata K, Takata Y, Goto T, Egawa H, Yasuoka S, Furouchi H, Hirasaka K, Nikawa T, Yasui N (2007) Distinct expression of mast cell tryptase and protease activated receptor-2 in synovia of rheumatoid arthritis and osteoarthritis. Clin Rheumatol 26(8):1284–1292. https://doi.org/10.1007/s10067-006-0495-8CrossRefPubMed

33.

Buckley MG, Walters C, Wong WM, Cawley MI, Ren S, Schwartz LB, Walls AF (1997) Mast cell activation in arthritis: detection of alpha- and beta-tryptase, histamine and eosinophil cationic protein in synovial fluid. Clin Sci (London, England : 1979) 93(4):363–370CrossRef

34.

Compten SJ, Cairns JA, Holgate ST, Walls AF (1998) The role of mast cell tryptase in regulating endothelial cell proliferation, cytokine release, and adhesion molecule expression: tryptase induces expression of mRNA for IL-1b and IL-8 and stimulates the selective release of IL-8 from human umbilical vein endothelial cells. J Immunol 161(4):1939–1946

35.

Malamud V, Vaaknin A, Abramsky O, Mor M, Burgess LE, Ben-Yehudah A (2013) Tryptase activates peripheral blood mononuclear cells causing the synthesis and release of TNF-alpha, IL-6, and IL-1 beta: possible relevance to multiple sclerosis. J Neuroimmunol 138:115–122CrossRef

36.

Shin K, Nigrovic PA, Crish J, Boilard E, McNeil HP, Larabee KS, Adachi R, Gurish MF, Gobezie R, Stevens RL, Lee DM (2009) Mast cells contribute to autoimmune inflammatory arthritis via their tryptase/heparin complexes. J Immunol (Baltimore, Md : 1950) 182(1):647–656CrossRef

37.

Shan L, van den Hoogen L, Meeldijk J, Kok HM, Jongeneel LH, Boes M, Wenink MH, Hack CE, Radstake TRDJ, van Roon JAG, Bovenschen N (2019) Increased intra-articular granzyme M may trigger local IFN-λ1/IL-29 response in rheumatoid arthritis. Clin Exp Rheumatol published online Jun 6. PubMed PMID: 31172927

38.

Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H, Group CS (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54(8):2665–2673. https://doi.org/10.1002/art.21972CrossRef

39.

Gladman DD, Shuckett R, Russell ML, Thorne JC, Schachter RK (1987) Psoriatic arthritis (PSA)--an analysis of 220 patients. Q J Med 62(238):127–141PubMed

40.

Karim Z, Wakefield RJ, Quinn M, Conaghan PG, Brown AK, Veale DJ, O’Connor P, Reece R, Emery P (2004) Validation and reproducibility of ultrasonography in the detection of synovitis in the knee: a comparison with arthroscopy and clinical examination. Arthritis Rheum 50(2):387–394. https://doi.org/10.1002/art.20054CrossRefPubMed

41.

Giles JT, Mease P, Boers M, Bresnihan B, Conaghan PG, Heald A, Maksymowych WP, Maillefert JF, Simon L, Tsuji W, Wakefield R, Woodworth T, Schumacher HR, Bingham CO 3rd (2007) Assessing single joints in arthritis clinical trials. J Rheumatol 34(3):641–647PubMed

42.

Gladman DD, Cook RJ, Schentag C, Feletar M, Inman RI, Hitchon C, Karsh J, Klinkhoff AV, Maksymowych WP, Mosher DP, Nair B, Stone MA (2004) The clinical assessment of patients with psoriatic arthritis: results of a reliability study of the spondyloarthritis research consortium of Canada. J Rheumatol 31(6):1126–1131PubMed

43.

Gladman DD, Inman RD, Cook RJ, Maksymowych WP, Braun J, Davis JC, Landewe RB, Mease P, Brandt J, Vargas RB, Chandran V, Helliwell P, Kavanaugh A, O’Shea FD, Khan MA, Pipitone N, Rahman P, Reveille JD, Stone MA, Taylor W, Veale DJ, van der Heijde D (2007) International spondyloarthritis interobserver reliability exercise--the INSPIRE study: II. Assessment of peripheral joints, enthesitis, and dactylitis. J Rheumatol 34(8):1740–1745PubMed

44.

Maricar N, Callaghan MJ, Felson DT, O’Neill TW (2013) Predictors of response to intra-articular steroid injections in knee osteoarthritis--a systematic review. Rheumatology (Oxford) 52(6):1022–1032. https://doi.org/10.1093/rheumatology/kes368CrossRef

45.

Fatimah N, Salim B, Raja EU, Nasim A (2016) Predictors of response to intra-articular steroid injections in patients with osteoarthritis of the knee joint. Clin Rheumatol 35(10):2541–2547. https://doi.org/10.1007/s10067-016-3365-zCrossRefPubMed

46.

Maricar N, Parkes MJ, Callaghan MJ, Hutchinson CE, Gait AD, Hodgson R, Felson DT, O’Neill TW (2017) Structural predictors of response to intra-articular steroid injection in symptomatic knee osteoarthritis. Arthritis research & therapy 19(1):88. https://doi.org/10.1186/s13075-017-1292-2CrossRef

47.

Jahangier ZN, Jacobs JW, Swen WA, Moolenburgh JD, Bruyn GA, Griep EN, Bijlsma JW (2011) Can simple ultrasonography predict the clinical effect of intra-articular injection therapy of the knee joint? Clin Rheumatol 30(6):749–755. https://doi.org/10.1007/s10067-010-1614-0CrossRefPubMed

48.

Vivarelli M, D’Urbano LE, Insalaco A, Lunt M, Jury F, Tozzi AE, Ravelli A, Martini A, Donn R, De Benedetti F (2007) Macrophage migration inhibitory factor (MIF) and oligoarticular juvenile idiopathic arthritis (o-JIA): association of MIF promoter polymorphisms with response to intra-articular glucocorticoids. Clin Exp Rheumatol 25(5):775–781PubMed

49.

Weitoft T, Ronnelid J, Knight A, Lysholm J, Saxne T, Larsson A (2014) Outcome predictors of intra-articular glucocorticoid treatment for knee synovitis in patients with rheumatoid arthritis - a prospective cohort study. Arthritis research & therapy 16(3):R129. https://doi.org/10.1186/ar4586CrossRef

50.

Colegrave N, Ruxton GD (2003) Confidence intervals are a more useful complement to nonsignificant tests than are power calculations. Behav Ecol 14(3):446–447CrossRef

Titel: The association between synovial fluid serine proteinase activity and response to intra-articular corticosteroid injection in psoriatic arthritis
verfasst von: Fatima Abji
Justine Yang Ye
Richard J Cook
Katerina Oikonomopoulou
Vinod Chandran
Publikationsdatum: 25.02.2020
Verlag: Springer International Publishing
Erschienen in: Clinical Rheumatology / Ausgabe 8/2020
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI: https://doi.org/10.1007/s10067-020-05003-9

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

19.04.2024 | Vorhofflimmern | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

The association between synovial fluid serine proteinase activity and response to intra-articular corticosteroid injection in psoriatic arthritis

Abstract

Introduction/objectives

Methods

Results

Conclusions

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Denken Sie bei starker Blutung auch an die Hemmkörper-Hämophilie

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Introduction/objectives

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2020

Response to “Quantitative measures of tissue mechanics to detect hypermobile Ehlers Danlos syndrome and hypermobility syndrome disorders: a systematic review”

Colchicine as a possible therapeutic option in COVID-19 infection

Chalk-stick fracture in ankylosing spondylitis

Preconceived notions about biosimilars—a French experience

Correction to: Sustained improvement in work outcomes in employed patients with rheumatoid arthritis during 2 years of adalimumab therapy: an observational cohort study

Clinical features and outcomes of the patients with anti-glycyl tRNA synthetase syndrome

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Denken Sie bei starker Blutung auch an die Hemmkörper-Hämophilie

Update Innere Medizin